HURRICANE CAPITAL ADVISORS LLC’s Indivior Pharmaceuticals INDV Stock Holding History

HURRICANE CAPITAL ADVISORS LLC’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.4K	Buy	+498	New	+$18.1K	0.01%	642

Other funds holding INDV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HURRICANE CAPITAL ADVISORS LLC's INDV Position: Q2 2026 in Review

HURRICANE CAPITAL ADVISORS LLC opened a new position in Indivior Pharmaceuticals (INDV) in Q2 2026: 498 shares worth $20.4K. The stake represents 0.01% of the portfolio and ranks #642 among its holdings.

341 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

HURRICANE CAPITAL ADVISORS LLC held 498 shares of Indivior Pharmaceuticals worth $20.4K as of Q2 2026.
Indivior Pharmaceuticals was a new HURRICANE CAPITAL ADVISORS LLC position in Q2 2026.
Indivior Pharmaceuticals made up 0.01% of HURRICANE CAPITAL ADVISORS LLC's portfolio in Q2 2026, its #642 holding.
341 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on HURRICANE CAPITAL ADVISORS LLC's 13F filing for Q2 2026, filed 3 Nov 2026.